Tria™ Firm M0061902220Recalls & reported problems
Boston Scientific Corporation · Ureteral Stent with Side Holes 6Fx24CM · Class 2 · Implant
All models of Tria Firm (14)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 11
- Deaths reported
- 0
- Injuries reported
- 2
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 11 adverse event reports that list this exact device (DI 08714729937845), received between Aug 2, 2019 and Apr 28, 2025 — classified as 2 injuries, 9 malfunctions.
The most frequently reported specific device problem is “Break” (6 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Most reported problems
Device problems
- Break6
- Calcified2
- Detachment of Device or Device Component2
- Adverse Event Without Identified Device or Use Problem1
- Difficult to Remove1
- Obstruction of Flow1
- Unsealed Device Packaging1
Patient problems
- No Clinical Signs, Symptoms or Conditions10
- No Known Impact Or Consequence To Patient1
- Unspecified Infection1
Recent adverse event reports
The 11 most recent of 11 reports, in the reporter's own words as published by the FDA.
MalfunctionApr 28, 2025Break; Break
IT WAS REPORTED THAT DURING THE PREPARATION, WHILE REMOVING THE SUTURE FROM THE STENT PRIOR TO PLACING IT IN THE PATIENT, IT CAUSED THE END OF THE STENT TO SNAP/BREAK OFF.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 21921956 ↗MalfunctionApr 22, 2025Break; Break
IT WAS REPORTED THAT A TRIA URETERAL STENT WAS USED IN A PROCEDURE. DURING THE PROCEDURE, IT WAS NOTICED THAT THE STENT WAS BROKEN. THE PROCEDURE WAS COMPLETED WITH ANOTHER OF THE SAME DEVICE AND THERE WERE NO PATIENT COMPLICATIONS REPORTED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 21879054 ↗MalfunctionMar 21, 2025Break; Detachment of Device or Device Component; Break; Detachment of Device or Device Component
IT WAS REPORTED THAT DURING PREPARATION, AFTER REMOVING THE PACKAGING, THE STENT WAS BROKEN WHEN THE THREAD WAS REMOVED. THE PROCEDURE WAS COMPLETED WITH ANOTHER OF THE SAME DEVICE AND THE PATIENT CONDITION WAS REPORTED TO BE STABLE.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 21665693 ↗MalfunctionJul 8, 2024Unsealed Device Packaging; Unsealed Device Packaging
IT WAS REPORTED THAT, DURING UNPACKING, THE SEAL OF THE TRIA URETERAL STENT PACKAGING WAS TORN.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 19697495 ↗MalfunctionSep 14, 2023Break; Break
IT WAS REPORTED TO BOSTON SCIENTIFIC CORPORATION THAT A TRIA FIRM URETERAL STENT WAS ATTEMPTED TO BE USED DURING A STENT REPLACEMENT PROCEDURE. THE EXACT EVENT DATE WAS NOT PROVIDED. DURING THE PROCEDURE, THE STENT WAS FOUND FRACTURED. THE PROCEDURE WAS SUCCESSFULLY COMPLETED WITH ANOTHER TRIA FIRM URETERAL STENT. THERE WERE NO PATIENT COMPLICATIONS REPORTED AS A RESULT OF THIS EVENT. THE PATIENT'S CONDITION AT THE CONCLUSION OF THE PROCEDURE WAS REPORTED TO BE AS NO PATIENT INJURY. BOSTON SCIENTIFIC HAS BEEN UNABLE TO OBTAIN ADDITIONAL INFORMATION REGARDING THE EVENT TO DATE, DESPITE GOOD FAITH EFFORTS.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 17749444 ↗MalfunctionMay 5, 2023Break; Break
IT WAS REPORTED A TRIA FIRM URETERAL STENT WAS USED DURING A STENT REPLACEMENT PROCEDURE IN THE URETER PERFORMED ON (B)(6) 2023. DURING THE PROCEDURE, THE STENT WAS SEPARATED WHEN REMOVING THE SUTURE. THE PROCEDURE WAS SUCCESSFULLY COMPLETED WITH ANOTHER TRIA FIRM URETERAL STENT DEVICE. THERE WERE NO PATIENT COMPLICATIONS REPORTED AS A RESULT OF THIS EVENT.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 16878085 ↗MalfunctionNov 16, 2022Calcified; Difficult to Remove; Calcified; Difficult to Remove
IT WAS REPORTED TO BOSTON SCIENTIFIC CORPORATION THAT A TRIA URETERAL STENT WAS USED IN A STENT PLACEMENT PROCEDURE FOR MALIGNANT OBSTRUCTION IN THE LEFT URETER PERFORMED ON (B)(6) 2022, AS PART OF THE U0652 DOUBLE-J REGISTRY CLINICAL STUDY. THE SUBJECT WAS PRE-STENTED ON (B)(6) 2021 WHICH WAS REMOVED ON (B)(6) 2022, AND A NEW TRIA URETERAL STENT WAS PLACED RETROGRADE ON THE LEFT URETER UNDER CYSTOSCOPY. THE STENT WAS SUCCESSFULLY IMPLANTED UNDER THE DIRECTION FOR USE AND WAS PERFORMED WITHOUT ANY COMPLICATIONS. DISCHARGE MEDICATIONS INCLUDED ANTIBIOTIC AND PHENAZOPYRIDINE. ON (B)(6) 2022, THE STENT WAS REMOVED SUCCESSFULLY AS PER THE INITIAL PLAN. PAIN CONTROL WAS REQUIRED AND MONITORED ANESTHESIA CARE (MAC). THE STENT WAS DIFFICULT TO REMOVE DUE TO ENCRUSTATION OF STENT BUT WAS SUCCESSFULLY REMOVED WITH THE USE OF CYSTO/GRASPERS. THE STENT WAS STILL ABLE TO DRAIN AT THE TIME OF THE PROCEDURE. ACCORDING TO THE COMPLAINANT, IT WAS FOUND THAT THE TRIA URETERAL STENT WAS ENCRUSTED. A NEW STENT WAS IMPLANTED TO THE PATIENT. THERE WERE NO PATIENT COMPLICATIONS REPORTED AS A RESULT OF THIS EVENT. ADDITIONAL INFORMATION WAS RECEIVED ON DECEMBER 05, 2022, THE ONSET DATE OF THE EVENT DIFFI
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 15807241 ↗InjuryOct 27, 2022Detachment of Device or Device Component; Detachment of Device or Device Component
IT WAS REPORTED, TO BOSTON SCIENTIFIC CORPORATION. THAT A TRIA FIRM URETERAL STENT WAS USED, DURING AN UNSPECIFIED PROCEDURE ON (B)(6) 2022. DURING THE WITHDRAWAL/CLOSURE OF THE PROCEDURE, THE COIL OF THE STENT DETACHED. THE DETACHED COIL WAS REMOVED VIA GRASPING FORCEPS UNDER RIGID URETEROSCOPY. THE PROCEDURE WAS COMPLETED WITH ANOTHER TRIA FIRM URETERAL STENT. THERE WAS NO PATIENT INJURY OR COMPLICATION AS A RESULT OF THE EVENT.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 15681830 ↗InjuryMar 20, 2022Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
IT WAS TO REPORTED BOSTON SCIENTIFIC CORPORATION THAT A PREVIOUSLY IMPLANTED TRIA FIRM URETERAL STENT WAS REMOVED FROM THE LEFT URETER, PERFORMED ON (B)(6) 2022 AS PART OF THE (B)(6) CLINICAL STUDY. THE TRIA URETERAL STENT WAS IMPLANTED ON (B)(6) 2021 WITH NO PROBLEMS REPORTED DURING PLACEMENT. ON (B)(6) 2022, IT WAS REPORTED THAT THE PATIENT PRESENTED IN THE ER WITH INFECTION. ON (B)(6) 2022, THE TRIA URETERAL STENTS WAS SUCCESSFULLY REMOVED FROM THE PATIENT IN THE OPERATING ROOM. NO ISSUES WERE REPORTED WITH THE DEVICE DURING REMOVAL. A TRIA FIRM URETERAL STENT WAS SUCCESSFULLY PLACED RETROGRADE ON THE LEFT SIDE UNDER FLUOROSCOPY. ON (B)(6) 2022 THE EVENT WAS CONSIDERED RESOLVED.
Patient problems: No Clinical Signs, Symptoms or Conditions; Unspecified Infection
MAUDE report 13830560 ↗MalfunctionJul 2, 2021Break; Break
IT WAS REPORTED TO BOSTON SCIENTIFIC CORPORATION THAT A TRIA URETERAL STENT WAS USED DURING A PROCEDURE IN THE URETER, PERFORMED ON AN UNKNOWN DATE. DURING PREPARATION, IT WAS NOTICED THAT THE STENT SHAFT WAS BROKEN. ANOTHER TRIA URETERAL STENT WAS OPENED AND SUCCESSFULLY COMPLETED THE PROCEDURE. THERE WERE NO PATIENT COMPLICATIONS REPORTED AS A RESULT OF THIS EVENT.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 12107426 ↗MalfunctionAug 2, 2019Calcified; Obstruction of Flow; Calcified; Obstruction of Flow
IT WAS REPORTED TO BOSTON SCIENTIFIC CORPORATION THAT A PREVIOUSLY IMPLANTED TRIA URETERAL STENT WAS USED REMOVED FROM A PATIENT DURING URETERAL STENT REMOVAL PROCEDURE PERFORMED IN THE URETER ON (B)(6) 2019. THE EXACT IMPLANT DATE WAS NOT PROVIDED. ACCORDING TO THE COMPLAINANT, THE STENT WAS IMPLANTED FOR 2 MONTHS AND WAS EXPLANTED ON (B)(6) 2019, WHEN THE PLANNED STENT REMOVAL PROCEDURE WAS PERFORMED, THE STENT WAS FOUND TO HAVE BLACK DISCOLORATION. IT WAS NOTICED THAT THE STENT WAS CALCIFIED AROUND THE BLADDER SIDE AND WAS OCCLUDED. REPORTEDLY, THE PHYSICIAN HAD TO CUT THE BLADDER SIDE OF THE STENT WITH A COOPER AND A GUIDEWIRE WAS INSERTED THROUGH THE STENT TO REMOVE THE STENT FROM THE PATIENT. ANOTHER TRIA URETERAL STENT WAS IMPLANTED AND SUCCESSFULLY COMPLETED THE PROCEDURE. THERE WAS NO SERIOUS INJURY, NOR WERE THERE ANY ADVERSE PATIENT EFFECTS REPORTED AS A RESULT OF THIS EVENT.
Patient problems: No Known Impact Or Consequence To Patient
MAUDE report 8857203 ↗
Other Stent, ureteral devices
- Bard® InLay Optima® Ureteral Stent 788426C. R. Bard, Inc. · STENT, URETERAL1 recall100 reports
- Bard® InLay Optima® Ureteral Stent 788626C. R. Bard, Inc. · STENT, URETERAL122 reports
- Bard® InLay® Ureteral Stent with HydroGlide™ Guidewire 777626C. R. Bard, Inc. · STENT, URETERAL118 reports
- Bard® InLay® Ureteral Stent with HydroGlide™ Guidewire 777426C. R. Bard, Inc. · STENT, URETERAL108 reports
- Bard® InLay® Ureteral Stent 778626C. R. Bard, Inc. · STENT, URETERAL100 reports
- Percuflex™ Plus M0061752530Boston Scientific Corporation · STENT, URETERAL1 death99 reports
- Contour VL™ M0061801560Boston Scientific Corporation · STENT, URETERAL1 recall45 reports
- Polaris™ Ultra M0061921330Boston Scientific Corporation · STENT, URETERAL71 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page